- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT05256225
Testowanie dodania trastuzumabu lub trastuzumabu/pertuzumabu do zwykłej chemioterapii w przypadku HER2-dodatniego raka surowiczego endometrium lub raka mięsaka macicy
Badanie fazy II/III paklitakselu/karboplatyny w monoterapii lub w skojarzeniu z trastuzumabem i hialuronidazą-Oysk (HERCEPTIN HYLECTA) lub pertuzumabem, trastuzumabem i hialuronidazą-Zzxf (PHESGO) w HER2-dodatnim raku surowiczym endometrium lub mięsakomięsaku endometrium w stadium I-IV
This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta [TM]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo [TM]) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial cancer. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When trastuzumab or pertuzumab attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Hyaluronidase is an endoglycosidase. It helps to keep pertuzumab and trastuzumab in the body longer, so that these medications will have a greater effect. Hyaluronidase also allows trastuzumab and trastuzumab/pertuzumab to be given by injection under the skin and shortens their administration time compared to trastuzumab or pertuzumab alone. Paclitaxel is a taxane and in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Giving Herceptin Hylecta or Phesgo in combination with paclitaxel and carboplatin may shrink the tumor and prevent the cancer from coming back in patients with HER2 positive endometrial cancer.
Przegląd badań
Status
Warunki
- Rak endometrium
- Gruczolakorak jasnokomórkowy endometrium
- Rak odróżnicowany endometrium
- Endometrialny gruczolakorak endometrioidalny
- Mieszany gruczolakokomórkowy endometrium
- Gruczolakorak surowiczy endometrium
- Niezróżnicowany rak endometrium
- Złośliwy mieszany mezenchymalny (przewodowy Müllera) guz trzonu macicy
Interwencja / Leczenie
- Lek: Carboplatin
- Lek: Paclitaxel
- Procedura: Computed Tomography
- Procedura: Echocardiography Test
- Procedura: Multigated Acquisition Scan
- Procedura: Biospecimen Collection
- Promieniowanie: High-Dose-Rate Vaginal Cuff Brachytherapy
- Inny: Survey Administration
- Lek: Trastuzumab/Hyaluronidase-oysk
- Lek: Hyaluronidase-zzxf/Pertuzumab/Trastuzumab
Szczegółowy opis
PRIMARY OBJECTIVES:
I. To evaluate the efficacy of trastuzumab and hyaluronidase-oysk (HERCEPTIN HYLECTA) and pertuzumab, trastuzumab, and hyaluronidase-zzxf (PHESGO) in combination with paclitaxel/carboplatin in patients with HER2 positive endometrial cancer.
SECONDARY OBJECTIVES:
I. To evaluate the efficacy of trastuzumab and hyaluronidase-oysk (HERCEPTIN HYLECTA) and pertuzumab, trastuzumab, and hyaluronidase-zzxf (PHESGO) in combination with paclitaxel/carboplatin in patients with HER2 positive endometrial cancer.
II. To evaluate the overall response rate (ORR) in patients with measurable disease.
III. To evaluate the duration of objective response in patients with measurable disease as assessed by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1.
IV. To determine the nature, frequency and degree of toxicity as assessed by Common Terminology Criteria for Adverse Events (CTCAE) version (v.) 5.0 for each treatment arm.
V. To compare quality of life (QOL), as measured by Functional Assessment of Cancer Therapy - Endometrial Trial Outcome Index (FACT-En-TOI), in the experimental versus control arms.
VI. To compare patient-reported treatment-associated symptoms (diarrhea and rash) as measured with the Patient Reported Outcomes (PRO) - CTCAE, patient-reported fatigue as measured with the Patient Reported Outcomes Measurement Information System (PROMIS)-Fatigue short form, and worry concerning side effects of treatment as measured by the item 'bothered by side effect', in the FACT-En TOI, respectively, in the experimental and control arms.
VII. To assess the correlation of HER2 immunohistochemistry (IHC) expression and in situ hybridization (ISH) amplification with clinical outcome and response to HER2 targeted therapies.
EXPLORATORY OBJECTIVE:
I. To explore time to sustained deterioration in quality of life, as measured by a drop in the FACT-En-TOI by 6 or more points lasting for more than one PRO time point, in the experimental and control arms.
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM I: Patients receive paclitaxel intravenously (IV) over 3 hours and carboplatin IV over 30-60 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with stable disease (SD) or partial response (PR) who still have measurable disease after completion of cycle 6 may receive 4 additional cycles of this treatment at the discretion of the treating physician.
ARM II: Patients receive paclitaxel IV over 3 hours, carboplatin IV over 30-60 minutes, and trastuzumab/hyaluronidase-oysk subcutaneously (SC) over 2-5 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease after completion of cycle 6 may receive 4 additional cycles of this treatment at the discretion of the treating physician.
MAINTENANCE: Patients receive trastuzumab/hyaluronidase-oysk SC over 2-5 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for up to 1 year in the absence of disease progression or unacceptable toxicity. Patients with SD or PR may continue maintenance therapy for up to 3 years from the start of treatment.
ARM III: Patients receive paclitaxel IV over 3 hours, carboplatin IV over 30-60 minutes, and pertuzumab/trastuzumab/hyaluronidase-zzxf SC over 5-8 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease after completion of cycle 6 may receive 4 additional cycles of this treatment at the discretion of the treating physician.
MAINTENANCE: Patients receive pertuzumab/trastuzumab/ hyaluronidase-zzxf SC over 5 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for up to 1 year in absence of disease progression or unacceptable toxicity. Patients with SD or PR may continue maintenance for up to 3 years from the start of treatment.
Patients undergo echocardiography (ECHO) or multigated acquisition scan (MUGA) and computed tomography (CT) throughout the study. Additionally, patients may optionally undergo blood sample collection throughout the study, vaginal brachytherapy on study, and urine sample collection prior to treatment.
After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 3 years.
Typ studiów
Zapisy (Szacowany)
Faza
- Faza 3
Kontakty i lokalizacje
Lokalizacje studiów
-
-
-
Seoul, Korea Południowa, 06273
- Gangnam Severance Hospital
-
-
Daegu
-
Dalseo-gu, Daegu, Korea Południowa, 42601
- Keimyung University-Dongsan Medical Center
-
-
Gyeongsangnam-do
-
Seoul, Gyeongsangnam-do, Korea Południowa, 51353
- Samsung Changwon Hospital
-
-
Kyeonggi-do
-
Seongnam, Kyeonggi-do, Korea Południowa, 463-707
- Seoul National University Bundang Hospital
-
-
-
-
-
San Juan, Portoryko, 00927
- Centro Comprensivo de Cancer de UPR
-
-
-
-
Alabama
-
Birmingham, Alabama, Stany Zjednoczone, 35233
- University of Alabama at Birmingham Cancer Center
-
-
Alaska
-
Anchorage, Alaska, Stany Zjednoczone, 99508
- Alaska Women's Cancer Care
-
-
Arizona
-
Tucson, Arizona, Stany Zjednoczone, 85719
- Banner University Medical Center - Tucson
-
Tucson, Arizona, Stany Zjednoczone, 85719
- University of Arizona Cancer Center-North Campus
-
-
Arkansas
-
Little Rock, Arkansas, Stany Zjednoczone, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Auburn, California, Stany Zjednoczone, 95602
- Sutter Auburn Faith Hospital
-
Berkeley, California, Stany Zjednoczone, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Concord, California, Stany Zjednoczone, 94520
- John Muir Medical Center-Concord
-
Duarte, California, Stany Zjednoczone, 91010
- City of Hope Comprehensive Cancer Center
-
Huntington Beach, California, Stany Zjednoczone, 92648
- City of Hope Seacliff
-
Irvine, California, Stany Zjednoczone, 92618
- Kaiser Permanente-Irvine
-
Irvine, California, Stany Zjednoczone, 92618
- City of Hope at Irvine Lennar
-
Irvine, California, Stany Zjednoczone, 92612
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
-
Long Beach, California, Stany Zjednoczone, 90813
- City of Hope at Long Beach Elm
-
Los Angeles, California, Stany Zjednoczone, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Modesto, California, Stany Zjednoczone, 95355
- Memorial Medical Center
-
Mountain View, California, Stany Zjednoczone, 94040
- Palo Alto Medical Foundation-Gynecologic Oncology
-
Orange, California, Stany Zjednoczone, 92868
- UC Irvine Health/Chao Family Comprehensive Cancer Center
-
Orange, California, Stany Zjednoczone, 92868
- Saint Joseph Hospital - Orange
-
Palo Alto, California, Stany Zjednoczone, 94304
- Stanford Cancer Institute Palo Alto
-
Panorama City, California, Stany Zjednoczone, 91402
- Kaiser Permanente - Panorama City
-
Riverside, California, Stany Zjednoczone, 92505
- Kaiser Permanente-Riverside
-
Roseville, California, Stany Zjednoczone, 95661
- Sutter Roseville Medical Center
-
Sacramento, California, Stany Zjednoczone, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, Stany Zjednoczone, 95817
- University of California Davis Comprehensive Cancer Center
-
San Francisco, California, Stany Zjednoczone, 94115
- California Pacific Medical Center-Pacific Campus
-
Santa Cruz, California, Stany Zjednoczone, 95065
- Palo Alto Medical Foundation-Santa Cruz
-
Sunnyvale, California, Stany Zjednoczone, 94086
- Palo Alto Medical Foundation-Sunnyvale
-
Upland, California, Stany Zjednoczone, 91786
- City of Hope Upland
-
Walnut Creek, California, Stany Zjednoczone, 94598
- John Muir Medical Center-Walnut Creek
-
-
Colorado
-
Aurora, Colorado, Stany Zjednoczone, 80045
- UCHealth University of Colorado Hospital
-
Denver, Colorado, Stany Zjednoczone, 80206
- UCHealth - Cherry Creek
-
Denver, Colorado, Stany Zjednoczone, 80210
- AdventHealth Porter
-
Grand Junction, Colorado, Stany Zjednoczone, 81505
- Grand Valley Oncology
-
Greeley, Colorado, Stany Zjednoczone, 80631
- Banner North Colorado Medical Center
-
Highlands Ranch, Colorado, Stany Zjednoczone, 80129
- UCHealth Highlands Ranch Hospital
-
Loveland, Colorado, Stany Zjednoczone, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
-
Connecticut
-
Danbury, Connecticut, Stany Zjednoczone, 06810
- Danbury Hospital
-
Derby, Connecticut, Stany Zjednoczone, 06418
- Smilow Cancer Hospital-Derby Care Center
-
Fairfield, Connecticut, Stany Zjednoczone, 06824
- Smilow Cancer Hospital Care Center-Fairfield
-
Glastonbury, Connecticut, Stany Zjednoczone, 06033
- Smilow Cancer Hospital Care Center at Glastonbury
-
Greenwich, Connecticut, Stany Zjednoczone, 06830
- Smilow Cancer Hospital Care Center at Greenwich
-
Guilford, Connecticut, Stany Zjednoczone, 06437
- Smilow Cancer Hospital Care Center - Guilford
-
Hartford, Connecticut, Stany Zjednoczone, 06105
- Smilow Cancer Hospital Care Center at Saint Francis
-
New Haven, Connecticut, Stany Zjednoczone, 06520
- Yale University
-
North Haven, Connecticut, Stany Zjednoczone, 06473
- Yale-New Haven Hospital North Haven Medical Center
-
Norwalk, Connecticut, Stany Zjednoczone, 06856
- Norwalk Hospital
-
Stamford, Connecticut, Stany Zjednoczone, 06902
- Smilow Cancer Hospital Care Center at Long Ridge
-
Torrington, Connecticut, Stany Zjednoczone, 06790
- Smilow Cancer Hospital-Torrington Care Center
-
Trumbull, Connecticut, Stany Zjednoczone, 06611
- Smilow Cancer Hospital Care Center-Trumbull
-
Waterbury, Connecticut, Stany Zjednoczone, 06708
- Smilow Cancer Hospital-Waterbury Care Center
-
Waterford, Connecticut, Stany Zjednoczone, 06385
- Smilow Cancer Hospital Care Center - Waterford
-
-
Delaware
-
Newark, Delaware, Stany Zjednoczone, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Stany Zjednoczone, 19713
- Medical Oncology Hematology Consultants PA
-
-
District of Columbia
-
Washington D.C., District of Columbia, Stany Zjednoczone, 20037
- George Washington University Medical Center
-
Washington D.C., District of Columbia, Stany Zjednoczone, 20016
- Sibley Memorial Hospital
-
-
Florida
-
Fort Lauderdale, Florida, Stany Zjednoczone, 33316
- Broward Health Medical Center
-
Jupiter, Florida, Stany Zjednoczone, 33458
- Jupiter Medical Center
-
N. Venice, Florida, Stany Zjednoczone, 34275
- Sarasota Memorial Hospital-Venice
-
Orlando, Florida, Stany Zjednoczone, 32803
- AdventHealth Orlando
-
Sarasota, Florida, Stany Zjednoczone, 34239
- Sarasota Memorial Hospital
-
Sarasota, Florida, Stany Zjednoczone, 34239
- Florida Cancer Specialists - Sarasota Downtown
-
Sarasota, Florida, Stany Zjednoczone, 34239
- FPG - Surgical Oncology Clinics Gynecologic Oncology Surgery
-
Venice, Florida, Stany Zjednoczone, 34275
- Florida Cancer Specialists - Venice Pinebrook
-
-
Georgia
-
Atlanta, Georgia, Stany Zjednoczone, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, Stany Zjednoczone, 30322
- Emory University Hospital/Winship Cancer Institute
-
Atlanta, Georgia, Stany Zjednoczone, 30342
- Emory Saint Joseph's Hospital
-
Atlanta, Georgia, Stany Zjednoczone, 30303
- Grady Health System
-
Atlanta, Georgia, Stany Zjednoczone, 30309
- Piedmont Hospital
-
Augusta, Georgia, Stany Zjednoczone, 30912
- Augusta University Medical Center
-
Decatur, Georgia, Stany Zjednoczone, 30033
- Emory Decatur Hospital
-
Savannah, Georgia, Stany Zjednoczone, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
-
Hawaii
-
Honolulu, Hawaii, Stany Zjednoczone, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Stany Zjednoczone, 96826
- Kapiolani Medical Center for Women and Children
-
-
Idaho
-
Boise, Idaho, Stany Zjednoczone, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise, Idaho, Stany Zjednoczone, 83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell, Idaho, Stany Zjednoczone, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Coeur d'Alene, Idaho, Stany Zjednoczone, 83814
- Kootenai Health - Coeur d'Alene
-
Fruitland, Idaho, Stany Zjednoczone, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, Stany Zjednoczone, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, Stany Zjednoczone, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
Nampa, Idaho, Stany Zjednoczone, 83687
- Saint Luke's Cancer Institute - Nampa
-
Post Falls, Idaho, Stany Zjednoczone, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint, Idaho, Stany Zjednoczone, 83864
- Kootenai Clinic Cancer Services - Sandpoint
-
Twin Falls, Idaho, Stany Zjednoczone, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Arlington Heights, Illinois, Stany Zjednoczone, 60005
- Northwest Community Hospital
-
Aurora, Illinois, Stany Zjednoczone, 60504
- Rush-Copley Medical Center
-
Centralia, Illinois, Stany Zjednoczone, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Stany Zjednoczone, 60611
- Northwestern University
-
Chicago, Illinois, Stany Zjednoczone, 60637
- University of Chicago Comprehensive Cancer Center
-
Chicago, Illinois, Stany Zjednoczone, 60612
- John H Stroger Jr Hospital of Cook County
-
Chicago, Illinois, Stany Zjednoczone, 60612
- Rush MD Anderson Cancer Center
-
Danville, Illinois, Stany Zjednoczone, 61832
- Carle at The Riverfront
-
DeKalb, Illinois, Stany Zjednoczone, 60115
- Northwestern Medicine Cancer Center Kishwaukee
-
Decatur, Illinois, Stany Zjednoczone, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Stany Zjednoczone, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Effingham, Illinois, Stany Zjednoczone, 62401
- Crossroads Cancer Center
-
Effingham, Illinois, Stany Zjednoczone, 62401
- Carle Physician Group-Effingham
-
Evanston, Illinois, Stany Zjednoczone, 60201
- NorthShore University HealthSystem-Evanston Hospital
-
Geneva, Illinois, Stany Zjednoczone, 60134
- Northwestern Medicine Cancer Center Delnor
-
Glenview, Illinois, Stany Zjednoczone, 60026
- NorthShore University HealthSystem-Glenbrook Hospital
-
Glenview, Illinois, Stany Zjednoczone, 60026
- Northwestern Medicine Glenview Outpatient Center
-
Grayslake, Illinois, Stany Zjednoczone, 60030
- Northwestern Medicine Grayslake Outpatient Center
-
Harvey, Illinois, Stany Zjednoczone, 60426
- Ingalls Memorial Hospital
-
Highland Park, Illinois, Stany Zjednoczone, 60035
- NorthShore University HealthSystem-Highland Park Hospital
-
Hinsdale, Illinois, Stany Zjednoczone, 60521
- Sudarshan K Sharma MD Limited-Gynecologic Oncology
-
Lake Forest, Illinois, Stany Zjednoczone, 60045
- Northwestern Medicine Lake Forest Hospital
-
Mattoon, Illinois, Stany Zjednoczone, 61938
- Carle Physician Group-Mattoon/Charleston
-
New Lenox, Illinois, Stany Zjednoczone, 60451
- UC Comprehensive Cancer Center at Silver Cross
-
Normal, Illinois, Stany Zjednoczone, 61761
- Carle Cancer Institute Normal
-
O'Fallon, Illinois, Stany Zjednoczone, 62269
- Cancer Care Center of O'Fallon
-
Orland Park, Illinois, Stany Zjednoczone, 60462
- University of Chicago Medicine-Orland Park
-
Orland Park, Illinois, Stany Zjednoczone, 60462
- Northwestern Medicine Orland Park
-
Rockford, Illinois, Stany Zjednoczone, 61114
- UW Health Carbone Cancer Center Rockford
-
Springfield, Illinois, Stany Zjednoczone, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Stany Zjednoczone, 62702
- Springfield Clinic
-
Springfield, Illinois, Stany Zjednoczone, 62781
- Springfield Memorial Hospital
-
Urbana, Illinois, Stany Zjednoczone, 61801
- Carle Cancer Center
-
Warrenville, Illinois, Stany Zjednoczone, 60555
- Northwestern Medicine Cancer Center Warrenville
-
Yorkville, Illinois, Stany Zjednoczone, 60560
- Rush-Copley Healthcare Center
-
-
Indiana
-
Carmel, Indiana, Stany Zjednoczone, 46032
- IU Health North Hospital
-
Crown Point, Indiana, Stany Zjednoczone, 46307
- UChicago Medicine Northwest Indiana
-
Crown Point, Indiana, Stany Zjednoczone, 46307
- Northwest Cancer Center - Crown Point
-
Dyer, Indiana, Stany Zjednoczone, 46311
- Northwest Oncology LLC
-
Goshen, Indiana, Stany Zjednoczone, 46526
- Goshen Center for Cancer Care
-
Hobart, Indiana, Stany Zjednoczone, 46342
- Northwest Cancer Center - Hobart
-
Hobart, Indiana, Stany Zjednoczone, 46342
- Saint Mary Medical Center
-
Indianapolis, Indiana, Stany Zjednoczone, 46237
- Franciscan Health Indianapolis
-
Indianapolis, Indiana, Stany Zjednoczone, 46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Indianapolis, Indiana, Stany Zjednoczone, 46260
- Ascension Saint Vincent Indianapolis Hospital
-
Indianapolis, Indiana, Stany Zjednoczone, 46312
- Saint Catherine Hospital
-
Lafayette, Indiana, Stany Zjednoczone, 47905
- Franciscan Saint Elizabeth Health - Lafayette East
-
Mooresville, Indiana, Stany Zjednoczone, 46158
- Franciscan Health Mooresville
-
Munster, Indiana, Stany Zjednoczone, 46321
- The Community Hospital
-
Munster, Indiana, Stany Zjednoczone, 46321
- Women's Diagnostic Center - Munster
-
South Bend, Indiana, Stany Zjednoczone, 46601
- Memorial Hospital of South Bend
-
Valparaiso, Indiana, Stany Zjednoczone, 46383
- Northwest Cancer Center - Valparaiso
-
-
Iowa
-
Ames, Iowa, Stany Zjednoczone, 50010
- Mary Greeley Medical Center
-
Ames, Iowa, Stany Zjednoczone, 50010
- McFarland Clinic - Ames
-
Boone, Iowa, Stany Zjednoczone, 50036
- McFarland Clinic - Boone
-
Council Bluffs, Iowa, Stany Zjednoczone, 51503
- Heartland Oncology and Hematology LLP
-
Council Bluffs, Iowa, Stany Zjednoczone, 51503
- Nebraska Cancer Specialists/Oncology Hematology West PC - MEJ
-
Fort Dodge, Iowa, Stany Zjednoczone, 50501
- McFarland Clinic - Trinity Cancer Center
-
Iowa City, Iowa, Stany Zjednoczone, 52242
- University of Iowa/Holden Comprehensive Cancer Center
-
Jefferson, Iowa, Stany Zjednoczone, 50129
- McFarland Clinic - Jefferson
-
Marshalltown, Iowa, Stany Zjednoczone, 50158
- McFarland Clinic - Marshalltown
-
-
Kansas
-
Shawnee Mission, Kansas, Stany Zjednoczone, 66204
- AdventHealth Shawnee Mission
-
-
Kentucky
-
Edgewood, Kentucky, Stany Zjednoczone, 41017
- Saint Elizabeth Healthcare Edgewood
-
Lexington, Kentucky, Stany Zjednoczone, 40503
- Baptist Health Lexington
-
Louisville, Kentucky, Stany Zjednoczone, 40207
- Baptist Health Louisville
-
-
Louisiana
-
Baton Rouge, Louisiana, Stany Zjednoczone, 70805
- LSU Health Baton Rouge-North Clinic
-
Baton Rouge, Louisiana, Stany Zjednoczone, 70817
- Our Lady of the Lake Medical Oncology
-
Baton Rouge, Louisiana, Stany Zjednoczone, 70808
- Our Lady of the Lake Physician Group
-
Covington, Louisiana, Stany Zjednoczone, 70433
- Ochsner Hematology Oncology North Shore - Covington (West Region)
-
Marrero, Louisiana, Stany Zjednoczone, 70072
- West Jefferson Medical Center
-
Metairie, Louisiana, Stany Zjednoczone, 70006
- East Jefferson General Hospital
-
Metairie, Louisiana, Stany Zjednoczone, 70006
- LSU Healthcare Network / Metairie Multi-Specialty Clinic
-
New Orleans, Louisiana, Stany Zjednoczone, 70121
- Ochsner Medical Center Jefferson
-
New Orleans, Louisiana, Stany Zjednoczone, 70112
- University Medical Center New Orleans
-
New Orleans, Louisiana, Stany Zjednoczone, 70115
- Ochsner Baptist Medical Center
-
-
Maine
-
Augusta, Maine, Stany Zjednoczone, 04330
- Harold Alfond Center for Cancer Care
-
Scarborough, Maine, Stany Zjednoczone, 04074
- MaineHealth Maine Medical Center- Scarborough
-
-
Maryland
-
Baltimore, Maryland, Stany Zjednoczone, 21237
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute
-
Baltimore, Maryland, Stany Zjednoczone, 21287
- Johns Hopkins University/Sidney Kimmel Cancer Center
-
Baltimore, Maryland, Stany Zjednoczone, 21215
- Sinai Hospital of Baltimore
-
Baltimore, Maryland, Stany Zjednoczone, 21204
- Greater Baltimore Medical Center
-
Bethesda, Maryland, Stany Zjednoczone, 20889-5600
- Walter Reed National Military Medical Center
-
Westminster, Maryland, Stany Zjednoczone, 21157
- William E Kahlert Regional Cancer Center/Sinai Hospital
-
-
Massachusetts
-
Springfield, Massachusetts, Stany Zjednoczone, 01199
- Baystate Medical Center
-
-
Michigan
-
Ann Arbor, Michigan, Stany Zjednoczone, 48109
- University of Michigan Rogel Cancer Center
-
Battle Creek, Michigan, Stany Zjednoczone, 49017
- Bronson Battle Creek
-
Brighton, Michigan, Stany Zjednoczone, 48114
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Canton, Michigan, Stany Zjednoczone, 48188
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Chelsea, Michigan, Stany Zjednoczone, 48118
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Detroit, Michigan, Stany Zjednoczone, 48201
- Wayne State University/Karmanos Cancer Institute
-
Farmington Hills, Michigan, Stany Zjednoczone, 48334
- Weisberg Cancer Treatment Center
-
Farmington Hills, Michigan, Stany Zjednoczone, 48336
- Corewell Health Farmington Hills Hospital
-
Flint, Michigan, Stany Zjednoczone, 48503
- Hurley Medical Center
-
Flint, Michigan, Stany Zjednoczone, 48503
- Genesee Hematology Oncology PC
-
Flint, Michigan, Stany Zjednoczone, 48503
- Genesys Hurley Cancer Institute
-
Flint, Michigan, Stany Zjednoczone, 48503
- Cancer Hematology Centers - Flint
-
Grand Rapids, Michigan, Stany Zjednoczone, 49503
- Trinity Health Grand Rapids Hospital
-
Grand Rapids, Michigan, Stany Zjednoczone, 49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Kalamazoo, Michigan, Stany Zjednoczone, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Stany Zjednoczone, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Stany Zjednoczone, 49009
- Beacon Kalamazoo Cancer Center
-
Lansing, Michigan, Stany Zjednoczone, 48912
- University of Michigan Health - Sparrow Lansing
-
Livonia, Michigan, Stany Zjednoczone, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Muskegon, Michigan, Stany Zjednoczone, 49444
- Trinity Health Muskegon Hospital
-
Niles, Michigan, Stany Zjednoczone, 49120
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Norton Shores, Michigan, Stany Zjednoczone, 49444
- Cancer and Hematology Centers of Western Michigan - Norton Shores
-
Pontiac, Michigan, Stany Zjednoczone, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Reed City, Michigan, Stany Zjednoczone, 49677
- Corewell Health Reed City Hospital
-
Royal Oak, Michigan, Stany Zjednoczone, 48073
- Corewell Health William Beaumont University Hospital
-
Saginaw, Michigan, Stany Zjednoczone, 48604
- Oncology Hematology Associates of Saginaw Valley PC
-
Saginaw, Michigan, Stany Zjednoczone, 48601
- MyMichigan Medical Center Saginaw
-
Saint Joseph, Michigan, Stany Zjednoczone, 49085
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Saint Joseph, Michigan, Stany Zjednoczone, 49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Tawas City, Michigan, Stany Zjednoczone, 48764
- MyMichigan Medical Center Tawas
-
Traverse City, Michigan, Stany Zjednoczone, 49684
- Munson Medical Center
-
Troy, Michigan, Stany Zjednoczone, 48085
- Corewell Health Beaumont Troy Hospital
-
West Branch, Michigan, Stany Zjednoczone, 48661
- Saint Mary's Oncology/Hematology Associates of West Branch
-
Wyoming, Michigan, Stany Zjednoczone, 49519
- University of Michigan Health - West
-
Ypsilanti, Michigan, Stany Zjednoczone, 48197
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
-
Minnesota
-
Coon Rapids, Minnesota, Stany Zjednoczone, 55433
- Mercy Hospital
-
Edina, Minnesota, Stany Zjednoczone, 55435
- Fairview Southdale Hospital
-
Edina, Minnesota, Stany Zjednoczone, 55435
- Minnesota Oncology - Edina
-
Maplewood, Minnesota, Stany Zjednoczone, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Marshall, Minnesota, Stany Zjednoczone, 56258
- Avera Cancer Institute at Marshall
-
Minneapolis, Minnesota, Stany Zjednoczone, 55407
- Abbott-Northwestern Hospital
-
Minneapolis, Minnesota, Stany Zjednoczone, 55455
- University of Minnesota/Masonic Cancer Center
-
Saint Louis Park, Minnesota, Stany Zjednoczone, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, Stany Zjednoczone, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Stany Zjednoczone, 55102
- United Hospital
-
Woodbury, Minnesota, Stany Zjednoczone, 55125
- Minnesota Oncology Hematology PA-Woodbury
-
-
Missouri
-
Columbia, Missouri, Stany Zjednoczone, 65212
- MU Health - University Hospital/Ellis Fischel Cancer Center
-
Rolla, Missouri, Stany Zjednoczone, 65401
- Phelps Health Delbert Day Cancer Institute
-
Springfield, Missouri, Stany Zjednoczone, 65807
- CoxHealth South Hospital
-
St Louis, Missouri, Stany Zjednoczone, 63110
- Washington University School of Medicine
-
St Louis, Missouri, Stany Zjednoczone, 63141
- Mercy Hospital Saint Louis
-
St Louis, Missouri, Stany Zjednoczone, 63128
- Mercy Hospital South
-
-
Montana
-
Anaconda, Montana, Stany Zjednoczone, 59711
- Community Hospital of Anaconda
-
Billings, Montana, Stany Zjednoczone, 59101
- Billings Clinic Cancer Center
-
Billings, Montana, Stany Zjednoczone, 59102
- Saint Vincent Frontier Cancer Center
-
Billings, Montana, Stany Zjednoczone, 59106
- Intermountain Health West End Clinic
-
Bozeman, Montana, Stany Zjednoczone, 59715
- Bozeman Health Deaconess Hospital
-
Great Falls, Montana, Stany Zjednoczone, 59405
- Benefis Sletten Cancer Institute
-
Kalispell, Montana, Stany Zjednoczone, 59901
- Logan Health Medical Center
-
Missoula, Montana, Stany Zjednoczone, 59802
- Saint Patrick Hospital - Community Hospital
-
Missoula, Montana, Stany Zjednoczone, 59804
- Community Medical Center
-
-
Nebraska
-
Omaha, Nebraska, Stany Zjednoczone, 68114
- Nebraska Methodist Hospital
-
Omaha, Nebraska, Stany Zjednoczone, 68198
- University of Nebraska Medical Center
-
Omaha, Nebraska, Stany Zjednoczone, 68124
- Alegent Health Bergan Mercy Medical Center
-
Omaha, Nebraska, Stany Zjednoczone, 68114
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC
-
-
Nevada
-
Las Vegas, Nevada, Stany Zjednoczone, 89102
- OptumCare Cancer Care at Charleston
-
Las Vegas, Nevada, Stany Zjednoczone, 89106
- Women's Cancer Center of Nevada
-
Las Vegas, Nevada, Stany Zjednoczone, 89183
- OptumCare Cancer Care at Fort Apache
-
-
New Jersey
-
Basking Ridge, New Jersey, Stany Zjednoczone, 07920
- Memorial Sloan Kettering Basking Ridge
-
Camden, New Jersey, Stany Zjednoczone, 08103
- Cooper Hospital University Medical Center
-
Hackensack, New Jersey, Stany Zjednoczone, 07601
- Hackensack University Medical Center
-
Lakewood, New Jersey, Stany Zjednoczone, 08701
- Monmouth Medical Center Southern Campus
-
Livingston, New Jersey, Stany Zjednoczone, 07039
- Cooperman Barnabas Medical Center
-
Long Branch, New Jersey, Stany Zjednoczone, 07740
- Monmouth Medical Center
-
Middletown, New Jersey, Stany Zjednoczone, 07748
- Memorial Sloan Kettering Monmouth
-
Montvale, New Jersey, Stany Zjednoczone, 07645
- Memorial Sloan Kettering Bergen
-
Moorestown, New Jersey, Stany Zjednoczone, 08057
- Virtua Samson Cancer Center
-
Neptune City, New Jersey, Stany Zjednoczone, 07753
- Jersey Shore Medical Center
-
New Brunswick, New Jersey, Stany Zjednoczone, 08903
- Rutgers Cancer Institute of New Jersey
-
Newark, New Jersey, Stany Zjednoczone, 07101
- Rutgers New Jersey Medical School
-
Red Bank, New Jersey, Stany Zjednoczone, 07701
- Riverview Medical Center/Booker Cancer Center
-
Sewell, New Jersey, Stany Zjednoczone, 08080
- Sidney Kimmel Cancer Center Washington Township
-
Somerville, New Jersey, Stany Zjednoczone, 08876
- Robert Wood Johnson University Hospital Somerset
-
Toms River, New Jersey, Stany Zjednoczone, 08755
- Community Medical Center
-
Voorhees Township, New Jersey, Stany Zjednoczone, 08043
- Virtua Voorhees
-
-
New Mexico
-
Albuquerque, New Mexico, Stany Zjednoczone, 87106
- University of New Mexico Cancer Center
-
Albuquerque, New Mexico, Stany Zjednoczone, 87110
- Presbyterian Kaseman Hospital
-
Rio Rancho, New Mexico, Stany Zjednoczone, 87124
- Presbyterian Rust Medical Center/Jorgensen Cancer Center
-
-
New York
-
Albany, New York, Stany Zjednoczone, 12208
- Women's Cancer Care Associates LLC
-
Commack, New York, Stany Zjednoczone, 11725
- Memorial Sloan Kettering Commack
-
Harrison, New York, Stany Zjednoczone, 10604
- Memorial Sloan Kettering Westchester
-
Mineola, New York, Stany Zjednoczone, 11501
- NYU Langone Hospital - Long Island
-
New York, New York, Stany Zjednoczone, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, Stany Zjednoczone, 10029
- Mount Sinai Hospital
-
New York, New York, Stany Zjednoczone, 10011
- Mount Sinai Chelsea
-
New York, New York, Stany Zjednoczone, 10016
- Laura and Isaac Perlmutter Cancer Center at NYU Langone
-
Rochester, New York, Stany Zjednoczone, 14642
- University of Rochester
-
Syracuse, New York, Stany Zjednoczone, 13210
- State University of New York Upstate Medical University
-
The Bronx, New York, Stany Zjednoczone, 10461
- Montefiore Medical Center-Einstein Campus
-
The Bronx, New York, Stany Zjednoczone, 10467
- Montefiore Medical Center - Moses Campus
-
The Bronx, New York, Stany Zjednoczone, 10461
- Montefiore Medical Center-Weiler Hospital
-
Uniondale, New York, Stany Zjednoczone, 11553
- Memorial Sloan Kettering Nassau
-
Webster, New York, Stany Zjednoczone, 14580
- Wilmot Cancer Institute at Webster
-
-
North Carolina
-
Cary, North Carolina, Stany Zjednoczone, 27518
- Duke Cancer Center Cary
-
Chapel Hill, North Carolina, Stany Zjednoczone, 27599
- UNC Lineberger Comprehensive Cancer Center
-
Durham, North Carolina, Stany Zjednoczone, 27710
- Duke University Medical Center
-
Greenville, North Carolina, Stany Zjednoczone, 27834
- ECU Health Medical Center
-
High Point, North Carolina, Stany Zjednoczone, 27262
- Hayworth Cancer Center
-
Raleigh, North Carolina, Stany Zjednoczone, 27607
- Duke Women's Cancer Care Raleigh
-
Wilmington, North Carolina, Stany Zjednoczone, 28401
- Novant Health New Hanover Regional Medical Center
-
Winston-Salem, North Carolina, Stany Zjednoczone, 27157
- Wake Forest University Health Sciences
-
-
North Dakota
-
Bismarck, North Dakota, Stany Zjednoczone, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, Stany Zjednoczone, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, Stany Zjednoczone, 58122
- Sanford Broadway Medical Center
-
-
Ohio
-
Beachwood, Ohio, Stany Zjednoczone, 44122
- UHHS-Chagrin Highlands Medical Center
-
Belpre, Ohio, Stany Zjednoczone, 45714
- Strecker Cancer Center-Belpre
-
Canton, Ohio, Stany Zjednoczone, 44710
- Aultman Health Foundation
-
Centerville, Ohio, Stany Zjednoczone, 45459
- Miami Valley Hospital South
-
Chardon, Ohio, Stany Zjednoczone, 44024
- Geauga Hospital
-
Chillicothe, Ohio, Stany Zjednoczone, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, Stany Zjednoczone, 45220
- Good Samaritan Hospital - Cincinnati
-
Cleveland, Ohio, Stany Zjednoczone, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Stany Zjednoczone, 44109
- MetroHealth Medical Center
-
Columbus, Ohio, Stany Zjednoczone, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Stany Zjednoczone, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, Stany Zjednoczone, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Stany Zjednoczone, 43213
- Mount Carmel East Hospital
-
Dayton, Ohio, Stany Zjednoczone, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Stany Zjednoczone, 45415
- Miami Valley Hospital North
-
Franklin, Ohio, Stany Zjednoczone, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Greenville, Ohio, Stany Zjednoczone, 45331
- Miami Valley Cancer Care and Infusion
-
Grove City, Ohio, Stany Zjednoczone, 43123
- Mount Carmel Grove City Hospital
-
Lancaster, Ohio, Stany Zjednoczone, 43130
- Fairfield Medical Center
-
Lima, Ohio, Stany Zjednoczone, 45801
- Saint Rita's Medical Center
-
Marietta, Ohio, Stany Zjednoczone, 45750
- Marietta Memorial Hospital
-
Marysville, Ohio, Stany Zjednoczone, 43040
- Memorial Hospital
-
Mentor, Ohio, Stany Zjednoczone, 44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Mount Vernon, Ohio, Stany Zjednoczone, 43050
- Knox Community Hospital
-
Newark, Ohio, Stany Zjednoczone, 43055
- Licking Memorial Hospital
-
Parma, Ohio, Stany Zjednoczone, 44129
- University Hospitals Parma Medical Center
-
Perrysburg, Ohio, Stany Zjednoczone, 43551
- Mercy Health - Perrysburg Hospital
-
Portsmouth, Ohio, Stany Zjednoczone, 45662
- Southern Ohio Medical Center
-
Springfield, Ohio, Stany Zjednoczone, 45504
- Springfield Regional Cancer Center
-
Springfield, Ohio, Stany Zjednoczone, 45504
- Springfield Regional Medical Center
-
Sylvania, Ohio, Stany Zjednoczone, 43560
- ProMedica Flower Hospital
-
Toledo, Ohio, Stany Zjednoczone, 43623
- Mercy Health - Saint Anne Hospital
-
Toledo, Ohio, Stany Zjednoczone, 43608
- Mercy Health - Saint Vincent Hospital
-
Troy, Ohio, Stany Zjednoczone, 45373
- Upper Valley Medical Center
-
Westerville, Ohio, Stany Zjednoczone, 43081
- Saint Ann's Hospital
-
Westlake, Ohio, Stany Zjednoczone, 44145
- UH Seidman Cancer Center at Saint John Medical Center
-
Zanesville, Ohio, Stany Zjednoczone, 43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Stany Zjednoczone, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, Stany Zjednoczone, 73120
- Mercy Hospital Oklahoma City
-
Tulsa, Oklahoma, Stany Zjednoczone, 74146
- Oklahoma Cancer Specialists and Research Institute-Tulsa
-
-
Oregon
-
Clackamas, Oregon, Stany Zjednoczone, 97015
- Providence Cancer Institute Clackamas Clinic
-
Newberg, Oregon, Stany Zjednoczone, 97132
- Providence Newberg Medical Center
-
Ontario, Oregon, Stany Zjednoczone, 97914
- Saint Alphonsus Cancer Care Center-Ontario
-
Portland, Oregon, Stany Zjednoczone, 97239
- Oregon Health and Science University
-
Portland, Oregon, Stany Zjednoczone, 97210
- Legacy Good Samaritan Hospital and Medical Center
-
Portland, Oregon, Stany Zjednoczone, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Stany Zjednoczone, 97225
- Providence Saint Vincent Medical Center
-
Tualatin, Oregon, Stany Zjednoczone, 97062
- Legacy Meridian Park Hospital
-
-
Pennsylvania
-
Allentown, Pennsylvania, Stany Zjednoczone, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Allentown, Pennsylvania, Stany Zjednoczone, 18104
- Saint Luke's Cancer Center - Allentown
-
Bethlehem, Pennsylvania, Stany Zjednoczone, 18017
- Lehigh Valley Hospital - Muhlenberg
-
Bethlehem, Pennsylvania, Stany Zjednoczone, 18015
- Saint Luke's University Hospital-Bethlehem Campus
-
Bryn Mawr, Pennsylvania, Stany Zjednoczone, 19010
- Bryn Mawr Hospital
-
East Stroudsburg, Pennsylvania, Stany Zjednoczone, 18301
- Pocono Medical Center
-
Easton, Pennsylvania, Stany Zjednoczone, 18045
- Saint Luke's Hospital-Anderson Campus
-
Erie, Pennsylvania, Stany Zjednoczone, 16544
- Saint Vincent Hospital
-
Hazleton, Pennsylvania, Stany Zjednoczone, 18201
- Lehigh Valley Hospital-Hazleton
-
Jefferson Hills, Pennsylvania, Stany Zjednoczone, 15025
- Jefferson Hospital
-
Media, Pennsylvania, Stany Zjednoczone, 19063
- Riddle Memorial Hospital
-
Monroeville, Pennsylvania, Stany Zjednoczone, 15146
- Forbes Hospital
-
Paoli, Pennsylvania, Stany Zjednoczone, 19301
- Paoli Memorial Hospital
-
Philadelphia, Pennsylvania, Stany Zjednoczone, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Stany Zjednoczone, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, Stany Zjednoczone, 19107
- Pennsylvania Hospital
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15224
- West Penn Hospital
-
Quakertown, Pennsylvania, Stany Zjednoczone, 18951
- Saint Luke's Hospital - Upper Bucks Campus
-
West Chester, Pennsylvania, Stany Zjednoczone, 19380
- Chester County Hospital
-
Wexford, Pennsylvania, Stany Zjednoczone, 15090
- Wexford Health and Wellness Pavilion
-
Willow Grove, Pennsylvania, Stany Zjednoczone, 19090
- Asplundh Cancer Pavilion
-
Wynnewood, Pennsylvania, Stany Zjednoczone, 19096
- Lankenau Medical Center
-
-
Rhode Island
-
Providence, Rhode Island, Stany Zjednoczone, 02905
- Women and Infants Hospital
-
Westerly, Rhode Island, Stany Zjednoczone, 02891
- Smilow Cancer Hospital Care Center - Westerly
-
-
South Carolina
-
Bluffton, South Carolina, Stany Zjednoczone, 29910
- Saint Joseph's/Candler - Bluffton Campus
-
Charleston, South Carolina, Stany Zjednoczone, 29425
- Medical University of South Carolina
-
-
South Dakota
-
Aberdeen, South Dakota, Stany Zjednoczone, 57401
- Avera Cancer Institute-Aberdeen
-
Rapid City, South Dakota, Stany Zjednoczone, 57701
- Rapid City Regional Hospital
-
Sioux Falls, South Dakota, Stany Zjednoczone, 57105
- Avera Cancer Institute
-
Sioux Falls, South Dakota, Stany Zjednoczone, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, Stany Zjednoczone, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Germantown, Tennessee, Stany Zjednoczone, 38138
- The West Clinic - Wolf River
-
-
Texas
-
Austin, Texas, Stany Zjednoczone, 78712
- University of Texas at Austin
-
Austin, Texas, Stany Zjednoczone, 78701
- Dell Seton Medical Center at The University of Texas
-
Dallas, Texas, Stany Zjednoczone, 75235
- Parkland Memorial Hospital
-
Dallas, Texas, Stany Zjednoczone, 75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
Fort Worth, Texas, Stany Zjednoczone, 76104
- UT Southwestern/Simmons Cancer Center-Fort Worth
-
Fort Worth, Texas, Stany Zjednoczone, 76104
- Tarrant County Hospital District/JPS Health Network
-
Houston, Texas, Stany Zjednoczone, 77030
- Houston Methodist Hospital
-
Houston, Texas, Stany Zjednoczone, 77030
- Memorial Hermann Texas Medical Center
-
Houston, Texas, Stany Zjednoczone, 77070
- Methodist Willowbrook Hospital
-
Houston, Texas, Stany Zjednoczone, 77094
- Houston Methodist West Hospital
-
Nassau Bay, Texas, Stany Zjednoczone, 77058
- Houston Methodist Saint John Hospital
-
Richardson, Texas, Stany Zjednoczone, 75080
- UT Southwestern Clinical Center at Richardson/Plano
-
Sugar Land, Texas, Stany Zjednoczone, 77479
- Houston Methodist Sugar Land Hospital
-
The Woodlands, Texas, Stany Zjednoczone, 77385
- Houston Methodist The Woodlands Hospital
-
-
Utah
-
Salt Lake City, Utah, Stany Zjednoczone, 84112
- Huntsman Cancer Institute/University of Utah
-
South Jordan, Utah, Stany Zjednoczone, 84009
- South Jordan Health Center
-
-
Virginia
-
Charlottesville, Virginia, Stany Zjednoczone, 22908
- University of Virginia Cancer Center
-
Richmond, Virginia, Stany Zjednoczone, 23235
- VCU Massey Cancer Center at Stony Point
-
Richmond, Virginia, Stany Zjednoczone, 23229
- Henrico Doctor's Hospital
-
Richmond, Virginia, Stany Zjednoczone, 23298
- VCU Massey Comprehensive Cancer Center
-
Roanoke, Virginia, Stany Zjednoczone, 24033
- Carilion Roanoke Memorial Hospital
-
-
Washington
-
Edmonds, Washington, Stany Zjednoczone, 98026
- Swedish Cancer Institute-Edmonds
-
Seattle, Washington, Stany Zjednoczone, 98122
- Swedish Medical Center-First Hill
-
Vancouver, Washington, Stany Zjednoczone, 98686
- Legacy Salmon Creek Hospital
-
-
West Virginia
-
Charleston, West Virginia, Stany Zjednoczone, 25304
- Vandalia Health/CAMC Institute for Academic Medicine
-
Morgantown, West Virginia, Stany Zjednoczone, 26506
- West Virginia University Healthcare
-
-
Wisconsin
-
Eau Claire, Wisconsin, Stany Zjednoczone, 54701
- Marshfield Medical Center-EC Cancer Center
-
Green Bay, Wisconsin, Stany Zjednoczone, 54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay, Wisconsin, Stany Zjednoczone, 54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
La Crosse, Wisconsin, Stany Zjednoczone, 54601
- Gundersen Lutheran Medical Center
-
Madison, Wisconsin, Stany Zjednoczone, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Madison, Wisconsin, Stany Zjednoczone, 53718
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
-
Marshfield, Wisconsin, Stany Zjednoczone, 54449
- Marshfield Medical Center-Marshfield
-
Milwaukee, Wisconsin, Stany Zjednoczone, 53226
- Medical College of Wisconsin
-
Minocqua, Wisconsin, Stany Zjednoczone, 54548
- Marshfield Medical Center - Minocqua
-
Mukwonago, Wisconsin, Stany Zjednoczone, 53149
- ProHealth D N Greenwald Center
-
New Richmond, Wisconsin, Stany Zjednoczone, 54017
- Cancer Center of Western Wisconsin
-
Oconomowoc, Wisconsin, Stany Zjednoczone, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Oconto Falls, Wisconsin, Stany Zjednoczone, 54154
- Saint Vincent Hospital Cancer Center at Oconto Falls
-
Rice Lake, Wisconsin, Stany Zjednoczone, 54868
- Marshfield Medical Center-Rice Lake
-
Sheboygan, Wisconsin, Stany Zjednoczone, 53081
- Saint Vincent Hospital Cancer Center at Sheboygan
-
Sheboygan, Wisconsin, Stany Zjednoczone, 53081
- Sheboygan Physicians Group
-
Stevens Point, Wisconsin, Stany Zjednoczone, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Sturgeon Bay, Wisconsin, Stany Zjednoczone, 54235-1495
- Saint Vincent Hospital Cancer Center at Sturgeon Bay
-
Waukesha, Wisconsin, Stany Zjednoczone, 53188
- UW Cancer Center at ProHealth Care
-
Weston, Wisconsin, Stany Zjednoczone, 54476
- Marshfield Medical Center - Weston
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
-
Federation of Gynecology and Obstetrics (FIGO) 2009 stage IA-IVB, non-recurrent, chemotherapy (chemo)-naive, HER2-positive endometrial cancer. The following endometrial cancer types are eligible:
-
Serous
-
Other endometrial cancers (including clear cell, endometrioid, mixed epithelial, dedifferentiated/undifferentiated)
-
Carcinosarcoma
- NOTE: Endometrial cancers that are mismatch repair deficient (dMMR) by IHC are not eligible
-
-
Histologic confirmation of the original primary tumor is required. Submission of surgical pathology report (or endometrial biopsy pathology report in patients who never undergo hysterectomy) is required
-
Patients must be within 8 weeks of primary surgery (or endometrial biopsy in patients who never undergo hysterectomy) at the time of study registration
-
Patients may have measurable disease, non-measurable disease, or no measurable disease. In patients with measurable disease, lesions will be defined and monitored by RECIST v 1.1. Measurable disease is defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded). Each lesion must be >= 10 mm when measured by CT or magnetic resonance imaging (MRI). Lymph nodes must be >= 15 mm in short axis when measured by CT or MRI
-
For patients with uterine-confined (stage I) disease, the tumor must be invasive into the myometrium. Any amount of myoinvasion is acceptable for eligibility. Patients with non-invasive disease, endometrial intraepithelial carcinoma alone, or disease confined to a polyp will be excluded
-
All patients must have tumors that are HER2 positive as defined by American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) 2018 Breast Cancer guidelines. IHC and ISH testing will be done locally, at each participating institution and interpreted by local pathologists. In general HER2 positivity is defined as any of the following:
- 3+ immunohistochemistry (IHC),
- 2+ IHC with positive in situ hybridization (ISH) Alternatively, patients could be eligible if next generation sequencing (NGS) demonstrates HER2 (ERBB2) amplification. NGS testing can be performed through any designated labs as per the National Cancer Institute (NCI) MATCH/NCI Combo-MATCH trial.
Pathology report showing results of institutional HER2 testing (or NGS testing results) must be submitted.
Sites must submit all results available (IHC, ISH, and NGS)
-
Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2
-
Age >= 18
-
Platelets >= 100,000/mcl (within 14 days prior to registration)
-
Absolute neutrophil count (ANC) >= 1,500/mcl (within 14 days prior to registration)
-
Creatinine =< 1.5 x institutional/laboratory upper limit of normal (ULN) or estimated Glomerular filtration rate (eGFR) >= 50 mL/min using either the Cockcroft-Gault equation, the Modification of Diet in Renal Disease Study, or as reported in the comprehensive metabolic panel/basic metabolic panel (eGFR) (within 14 days prior to registration)
-
Total serum bilirubin level =< 1.5 x ULN (patients with known Gilbert's disease who have bilirubin level =< 3 x ULN may be enrolled) (within 14 days prior to registration)
-
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3 x ULN (within 14 days prior to registration)
-
Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of registration are eligible for this trial
-
Although the uterus will have been removed in the vast majority of patients, for patients of child-bearing potential: negative urine or serum pregnancy test. If the urine test is positive or cannot be confirmed as negative, a serum pregnancy test is required. Patients will be considered of non-reproductive potential if they are either:
- Postmenopausal (defined as at least 12 months with no menses without an alternative medical cause; in women < 45 years of age, a high follicle stimulating hormone [FSH] level in the postmenopausal range may be used to confirm a postmenopausal state in women not using hormonal contraception or hormonal replacement therapy. In the absence of 12 months of amenorrhea, a single FSH measurement is insufficient); OR
- Have had a hysterectomy and/or bilateral oophorectomy, bilateral salpingectomy or bilateral tubal ligation/occlusion at least 6 weeks prior to registration
- Have a congenital or acquired condition that prevents childbearing
-
Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial
-
Patients with evidence of chronic hepatitis B virus (HBV) infection must have an undetectable HBV viral load on suppressive therapy, if indicated
-
Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load
-
Patients with treated brain metastases are eligible if follow-up brain imaging after central nervous system (CNS)-directed therapy shows no evidence of progression
-
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry and, for patients treated in the United States (U.S.), authorization permitting release of personal health information
Exclusion Criteria:
-
Prior Therapy:
-
Patients must NOT have received prior chemotherapy, biologic therapy, or targeted therapy for treatment of endometrial carcinoma
-
Patients must NOT have received prior radiation therapy for treatment of endometrial carcinoma. Prior radiation includes external beam pelvic radiation therapy, external beam extended field pelvic/para-aortic radiation therapy, and/or intravaginal brachytherapy
- NOTE: Vaginal brachytherapy for treatment of endometrial cancer is permitted during study treatment. Planned use of vaginal brachytherapy must be declared at time of registration
-
Patients may have received prior hormonal therapy for treatment of endometrial carcinoma. All hormonal therapy must be discontinued at least one week prior to registration
-
-
Patients may not have a planned interval cytoreduction or hysterectomy, prior to documentation of progression, after study registration
-
Patients may not have planned external beam radiotherapy, prior to documentation of progression, after study registration
-
Significant cardiovascular disease including:
- Uncontrolled hypertension, defined as systolic > 150 mm Hg or diastolic > 90 mm Hg despite antihypertensive medications
- Myocardial infarction or unstable angina within 6 months prior to registration
- New York Heart Association functional classification II, III or IV
- Serious cardiac arrhythmia requiring medication. This does not include asymptomatic, atrial fibrillation with controlled ventricular rate
-
Significant lung disease: dyspnea at rest grade 2 or greater (resulting from extensive tumor involvement or other causes), pneumonitis grade 2 or greater, interstitial lung disease grade 2 or greater, idiopathic pulmonary fibrosis, cystic fibrosis, Aspergillosis, active tuberculosis, or history of opportunistic infections (pneumocystis pneumonia or cytomegalovirus pneumonia)
-
Patients with uncontrolled intercurrent illness including, but not limited to: ongoing or active infection (except for uncomplicated urinary tract infection), uncontrolled interstitial lung disease, symptomatic congestive heart failure, or psychiatric illness/social situations that would limit compliance with study requirements
-
Treatment with strong CYP2C8 or CYP3A4 inhibitors or inducers within 14 days or 5 drug-elimination half-lives, whichever is longer, prior to registration
-
Women who are unwilling to discontinue nursing
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Aktywny komparator: Arm I (paclitaxel, carboplatin)
Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30-60 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease after completion of cycle 6 may receive 4 additional cycles of this treatment at the discretion of the treating physician. Patients undergo ECHO or MUGA and CT throughout the study. Additionally, patients may optionally undergo blood sample collection throughout the study, vaginal brachytherapy on study, and urine sample collection prior to treatment. |
Given IV
Inne nazwy:
Given IV
Inne nazwy:
Undergo CT
Inne nazwy:
Undergo ECHO
Inne nazwy:
Undergo MUGA
Inne nazwy:
Undergo blood and urine sample collection
Inne nazwy:
Undergo vaginal brachytherapy
Inne nazwy:
|
|
Eksperymentalny: Arm II (paclitaxel, carboplatin, Herceptin Hylecta)
Patients receive paclitaxel IV over 3 hours, carboplatin IV over 30-60 minutes, and trastuzumab/hyaluronidase-oysk SC over 2-5 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease after completion of cycle 6 may receive 4 additional cycles of this treatment at the discretion of the treating physician. MAINTENANCE: Patients receive trastuzumab/hyaluronidase-oysk SC over 2-5 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for up to 1 year in the absence of disease progression or unacceptable toxicity. Patients with SD or PR may continue maintenance therapy for up to 3 years from the start of treatment. Patients undergo ECHO or MUGA and CT throughout the study. Additionally patients may optionally undergo blood sample collection throughout the study, vaginal brachytherapy on study, and urine sample collection prior to treatment. |
Given IV
Inne nazwy:
Given IV
Inne nazwy:
Undergo CT
Inne nazwy:
Undergo ECHO
Inne nazwy:
Undergo MUGA
Inne nazwy:
Undergo blood and urine sample collection
Inne nazwy:
Undergo vaginal brachytherapy
Inne nazwy:
Ancillary studies Given SC
Inne nazwy:
|
|
Eksperymentalny: Arm III (paclitaxel, carboplatin, Phesgo)
See Detailed Description. |
Given IV
Inne nazwy:
Given IV
Inne nazwy:
Undergo CT
Inne nazwy:
Undergo ECHO
Inne nazwy:
Undergo MUGA
Inne nazwy:
Undergo blood and urine sample collection
Inne nazwy:
Undergo vaginal brachytherapy
Inne nazwy:
Ancillary studies Given SC
Inne nazwy:
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Progression free survival
Ramy czasowe: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years from randomization
|
At the end of Phase 2 analysis, if both experimental arms demonstrate superiority to the reference, the experimental arms will be compared to each other. |
From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years from randomization
|
|
Overall survival
Ramy czasowe: From study entry to time of death or the date of last contact, assessed up to 5 years from randomization
|
If both experimental arms demonstrate superiority to the reference arm, the experimental arms will be compared to each other. |
From study entry to time of death or the date of last contact, assessed up to 5 years from randomization
|
|
Incidence of dose limiting toxicities
Ramy czasowe: Up to end of cycle 3 (week 12)
|
A dose limiting toxicity is any treatment-related adverse event requiring permanent discontinuation of the experimental therapy prior to the completion of treatment cycle 3. |
Up to end of cycle 3 (week 12)
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Objective response rate (ORR)
Ramy czasowe: Within 12 months of initiating maintenance therapy
|
Defined as the binomial proportion of evaluable patients with a best overall response of complete response or partial response (by Response Evaluation Criteria in Solid Tumors 1.1) within 12 months of initiating maintenance therapy. Responses reported by the treating physician will be used for these analyses. The ORR estimates by treatment arm will be supported by their 2-sided, 95% Wilson-Score confidence intervals (Wilson, 1927; Agresti, 1998). The relative odds of response in each experimental group (versus [vs] the reference group) will be estimated using a multivariable logistic regression model specified with main effects for the treatment groups and covariate adjustments for the stratification factors reported at baseline. |
Within 12 months of initiating maintenance therapy
|
|
Duration of objective response
Ramy czasowe: From documentation of either partial response or complete response until disease progression or death, whichever is observed first, assessed up to 5 years from randomization
|
Treatment group differences in response duration will be graphed using Kaplan-Meier methods and compared using logrank tests, stratified by the minimization factors defined at randomization. The relative hazards of progression or death in each experimental group (vs the reference group) will be estimated using a multivariable proportional hazards regression model specified with main effects for the treatment indicators and covariate adjustments for the stratification factors reported at baseline. |
From documentation of either partial response or complete response until disease progression or death, whichever is observed first, assessed up to 5 years from randomization
|
|
Incidence of adverse events (AEs)
Ramy czasowe: Up to 5 years from randomization
|
The nature, frequency, and degree of toxicity will be tabulated at the System Organ Class and AE-specific term levels using Common Terminology Criteria version 5.0. Each patient will be represented according to the maximum grade observed for each term. Tabulations will show the number and percentage of patients by maximum grade, within the treatment group received, regardless of the randomized treatment assignment. |
Up to 5 years from randomization
|
|
HER2 expression
Ramy czasowe: Up to 5 years from randomization
|
Correlation of HER2 immunohistochemistry expression and in situ hybridization amplification with clinical outcome and response to HER2 targeted therapies will be explored. |
Up to 5 years from randomization
|
|
Quality of life (QoL)
Ramy czasowe: Up to 5 years from randomization
|
Measured by Functional Assessment of Cancer Therapy - Endometrial Trial Outcome Index (FACT-En TOI). |
Up to 5 years from randomization
|
Inne miary wyników
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
QoL deterioration
Ramy czasowe: Baseline up to 5 years
|
The deterioration in QoL will be measured by a drop of >= 6 points in the FACT-En TOI score from baseline and lasting for more than one patient reported outcome time point in experimental and control arms. |
Baseline up to 5 years
|
Współpracownicy i badacze
Sponsor
Współpracownicy
Śledczy
- Główny śledczy: Britt K Erickson, NRG Oncology
Publikacje i pomocne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Szacowany)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
- Choroby układu moczowo-płciowego
- Choroby narządów płciowych
- Nowotwory układu moczowo-płciowego
- Nowotwory według lokalizacji
- Choroby układu moczowo-płciowego kobiet
- Choroby układu moczowo-płciowego kobiet i powikłania ciąży
- Choroby macicy
- Choroby narządów płciowych, kobiety
- Nowotwory narządów płciowych, kobiety
- Nowotwory macicy
- Nowotwory
- Nowotwory endometrium
- Aminokwasy, peptydy i białka
- Białka
- Organiczne chemikalia
- Techniki śledcze
- Techniki laboratoryjne kliniczne
- Techniki i procedury diagnostyczne
- Diagnoza
- Węglowodory
- Cykloparafiny
- Węglowodory, Alicyklic
- Węglowodory, cykliczne
- Terpeny
- Hydrolazy glikozydowe
- Hydrolazy
- Enzymy
- Enzymy i koenzymy
- Polisacharyd-Lyaza
- Lyaza z tlenkiem węgla
- Lyazy
- Przeciwciała, monoklonalne, humanizowane
- Przeciwciała, monoklonalne
- Przeciwciała
- Immunoglobuliny
- Immunoproteiny
- Białka krwi
- Globuliny w surowicy
- Globuliny
- Kompleksy koordynacyjne
- Taksoidy
- Cyklodekan
- Diterpenes
- Ekonomia i organizacje opieki zdrowotnej
- Ekonomika
- Trastuzumab
- Karboplatyna
- Paklitaksel
- Hialuronoglukozaminidaza
- Prowadzenie okazów
- pertuzumab
- Podatki
Inne numery identyfikacyjne badania
- NCI-2022-01540
- U10CA180868 (Grant/umowa NIH USA)
- NCI-2022-01540 (Identyfikator rejestru: CTRP (Clinical Trial Reporting Program))
- NRG-GY026 (Inny identyfikator: CTEP)
- NRG-GY026 (Inny identyfikator: NRG Oncology)
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .